News

Personalized medicine is still more a potential than a reality

New Valdosta, GA, facility is targeted at independent pharmacies in the Southeast

War-gaming analyst picks the drug distributor over Microsoft, Allscripts and other EMR players

States pile on rules; industry wishes for consistency

Model N’s annual analysis of commercial operations finds lost revenue and a lack of IT tools

States continue to push for a ‘bio-economic’ foundation

The current economic downturn may fuel the creation of new, more sustainable business models

Spurred by some recent successful launches, and with hefty R&D funding commitments, the vaccine business is booming

Sustainability initiatives add to the complexity of managing reverse logistics for life sciences products

States continue to push for a ‘bio-economic’ foundation

Drug sponsors have options in both how the new FDA risk programs are structured and how to execute them

As direct-to-consumer advertising declines, vendors offer tactical aids to marketers

Supply-chain monitoring program to be run by healthcare-analytics company

Deals illustrate big pharma’s growing reliance on formerly eschewed market sectors

New metrics to factor into drug approvals

Poor reconciliation of chargebacks, plus faulty product-returns crediting, are the sources, says Health Industry Insights. Product serialization will provide invaluable tools, but industry shouldn’t wait for widespread adoption

Cigna and Merck sign “unique” contract for Januvia and Janumet diabetes meds

Medco and Indiana Univ. study patient health records

Web-based strategies seen as cost-effective in survey

AcuTemp unit remains the only FAA-approved container for domestic US use

Unfair competition accusations accompany revenue rise

Meanwhile, new report counts low- and medium-access physicians

Product demand driven by mass media hype

Evaluating medicine and healthcare by their outcomes is now an NIH priority

Sweden is to be the site of the high-profile project